Novel Oxovanadium(V)‐Pyrazole Chalcone Complexes as Multifunctional Antidiabetic Agents With Antioxidant Activity: SAR Integrated Experimental and Computational Investigations

The design of multitargeted metal‐centred therapeutics presents an attractive approach to concurrently addressing different pathophysiological pathways involved in diabetes. In the current work, new series of oxovanadium(V) complexes [VO (L I‐V ) 2 Cl 3 ] containing biologically active pyrazole‐chalcone ligands L I‐V where L I = (1‐(5‐methyl‐1‐phenyl‐1H‐pyrazol‐4‐yl)‐3‐(m‐tolyl)prop‐2‐en‐1‐one), L II = (3‐(2,4‐dichlorophenyl)‐1‐(5‐methyl‐1‐phenyl‐1H‐pyrazol‐4‐yl)prop‐2‐en‐1‐one), L III = (1‐(5‐methyl‐1‐phenyl‐1H‐pyrazol‐4‐yl)‐3‐(3‐nitrophenyl) prop‐2‐en‐1‐one), L IV = (3‐(1H‐indol‐5‐yl)‐1‐(5‐methyl‐1‐phenyl‐1H‐pyrazol‐4‐yl) prop‐2‐en‐1‐one) and L V = (3‐(4‐hydroxyphenyl)‐1‐(5‐methyl‐1‐phenyl‐1H‐pyrazol‐4‐yl)prop‐2‐en‐1‐one) have been rationally designed, synthesised and fully studied to be potentially used as antidiabetic agents (J1–J5). All synthesised complexes were characterised by physio analytical analysis (EDS, molar conductivity as well as chlorine estimation) and various spectroscopic techniques viz . UV‐Vis, FTIR, 1 H‐NMR, HRMS ion fragmentation mass study to confirm the successful formation of oxovanadium(V) coordination complexes. In this series, complex J3 showed the best inhibition of α‐glucosidase (IC 50 = 14.56 ± 1.6 μM) that far exceeds acarbose as a reference drug while it was also recorded complex J1 presented greater activity on α‐amylase inhibitory effects (IC 50 = 94.26 ± 1.3 μM) in accordance with standard inhibitors modes. Antioxidant evaluation also showed potential DPPH radical scavenging effect including complex J5 being the most potent antioxidant (IC 50 = 10.20 ± 1.4 μg/mL) confirming that a portion of its biological activity might be mediated through its complementary antioxidant role in combating oxidative stress linked to diabetes. Molecular docking revealed strong binding of complexes towards α‐glucosidase and α‐amylase consistent with their inhibitory activities, while DFT elucidated their electronic structures and structure activity relationship and further ADMET analysis indicated favourable drug likeness with moderate oral bioavailability despite inherent physiochemical limitations of metal complexes.

Authors

Institutions

Publication Details

Journal
Applied Organometallic Chemistry
Published
2026-11-20
DOI
https://doi.org/10.1002/aoc.70695
Primary Topic
Vanadium and Halogenation Chemistry
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Novel Oxovanadium(V)‐Pyrazole Chalcone Complexes as Multifunctional Antidiabetic Agents With Antioxidant Activity: SAR Integrated Experimental and Computational Investigations

Raj Kaushal, J. N. Sharma
Applied Organometallic Chemistry
Vanadium and Halogenation Chemistry
article

Novel Oxovanadium(V)‐Pyrazole Chalcone Complexes as Multifunctional Antidiabetic Agents With Antioxidant Activity: SAR Integrated Experimental and Computational Investigations

Raj Kaushal, J. N. Sharma
article en

Abstract

The design of multitargeted metal‐centred therapeutics presents an attractive approach to concurrently addressing different pathophysiological pathways involved in diabetes. In the current work, new series of oxovanadium(V) complexes [VO (L I‐V ) 2 Cl 3 ] containing biologically active pyrazole‐chalcone ligands L I‐V where L I = (1‐(5‐methyl‐1‐phenyl‐1H‐pyrazol‐4‐yl)‐3‐(m‐tolyl)prop‐2‐en‐1‐one), L II = (3‐(2,4‐dichlorophenyl)‐1‐(5‐methyl‐1‐phenyl‐1H‐pyrazol‐4‐yl)prop‐2‐en‐1‐one), L III = (1‐(5‐methyl‐1‐phenyl‐1H‐pyrazol‐4‐yl)‐3‐(3‐nitrophenyl) prop‐2‐en‐1‐one), L IV = (3‐(1H‐indol‐5‐yl)‐1‐(5‐methyl‐1‐phenyl‐1H‐pyrazol‐4‐yl) prop‐2‐en‐1‐one) and L V = (3‐(4‐hydroxyphenyl)‐1‐(5‐methyl‐1‐phenyl‐1H‐pyrazol‐4‐yl)prop‐2‐en‐1‐one) have been rationally designed, synthesised and fully studied to be potentially used as antidiabetic agents (J1–J5). All synthesised complexes were characterised by physio analytical analysis (EDS, molar conductivity as well as chlorine estimation) and various spectroscopic techniques viz . UV‐Vis, FTIR, 1 H‐NMR, HRMS ion fragmentation mass study to confirm the successful formation of oxovanadium(V) coordination complexes. In this series, complex J3 showed the best inhibition of α‐glucosidase (IC 50 = 14.56 ± 1.6 μM) that far exceeds acarbose as a reference drug while it was also recorded complex J1 presented greater activity on α‐amylase inhibitory effects (IC 50 = 94.26 ± 1.3 μM) in accordance with standard inhibitors modes. Antioxidant evaluation also showed potential DPPH radical scavenging effect including complex J5 being the most potent antioxidant (IC 50 = 10.20 ± 1.4 μg/mL) confirming that a portion of its biological activity might be mediated through its complementary antioxidant role in combating oxidative stress linked to diabetes. Molecular docking revealed strong binding of complexes towards α‐glucosidase and α‐amylase consistent with their inhibitory activities, while DFT elucidated their electronic structures and structure activity relationship and further ADMET analysis indicated favourable drug likeness with moderate oral bioavailability despite inherent physiochemical limitations of metal complexes.

Applied Organometallic ChemistryVol. 40(12)
National Institute of Technology Hamirpur (BD)
Ministry of Education, India
Good health and well-being
Vanadium and Halogenation Chemistry
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon